Clinical trial
Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis
NCT04778943 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis
- Lead sponsor
- Tang-Du Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2021
- Completion date
- March 29, 2021
- Enrollment
- 130 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lumbar spinal stenosis